Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Other Molds”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Large-scale testing (Phase 3)Ended earlyNCT00836875
What this trial is testing

Evaluate The Safety Of Voriconazole As Treatment Of Invasive Aspergillosis (Fungal Infection) And Other Rare Molds In Children

Who this might be right for
Invasive Aspergillosis
Pfizer 31
Large-scale testing (Phase 3)Looking for participantsNCT06925321
What this trial is testing

Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections.

Who this might be right for
Invasive Mold Infections
Basilea Pharmaceutica 234
Post-approval studies (Phase 4)Study completedNCT05630976
What this trial is testing

Cresemba® in Treating Chinese Patients With IFD Caused by Aspergillus Species or Other Filamentous Fungi

Who this might be right for
Invasive Fungal Disease
Pfizer 70
Large-scale testing (Phase 3)Study completedNCT00412893
What this trial is testing

Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis

Who this might be right for
AspergillosisInvasive Fungal Infection
Astellas Pharma Inc 527
Early research (Phase 1)Looking for participantsNCT07704333
What this trial is testing

Assessment of [18F]-Fluorocellobiose ([18F]FCB) Pharmacokinetics in Healthy Volunteers and Subjects With Invasive Mold Infections

Who this might be right for
AspergillosMucormyeDimorphic+3 more
National Institutes of Health Clinical Center (CC) 100
Not applicableAvailableNCT06433128
What this trial is testing

Expanded Access to Fosmanogepix for Patients With Serious or Life-threatening Invasive Fungal Infections

Who this might be right for
Invasive Fungal Infections
Basilea Pharmaceutica